<?xml version="1.0" encoding="UTF-8"?>
<svg height="777.49" width="545.202" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M49.610 53.720 L532.910 53.720 "/>
  <g begin="text">
   <text y="49.34" x="49.606,54.606,59.606,64.606" svgx:width="0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">352 </text>
   <text y="49.34" x="438.646,443.126,447.606,451.146,453.956,458.336,461.466,464.246,468.826,473.206,476.746,480.286,482.166,486.646,491.336,494.116,499.326,501.306,504.086,509.296,514.506,517.286,520.206,524.786,529.996" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1)</text>
  </g>
  <g begin="text">
   <text y="767.49" x="49.606,57.736,62.426,64.306,67.116,68.996,73.896,75.776,80.156,82.936,87.516,91.366,93.246,97.626,100.756,105.236,108.776,110.656,114.196,116.976,119.376,123.856,128.546,131.676,136.366,141.056" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="767.49" x="142.936,145.716,150.716,155.716,160.716,165.716,167.906,170.686,175.686,180.686,182.876,185.656,188.886,193.466,198.466,201.696,204.476,209.476,214.476,219.476,224.476,229.476,234.476" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="767.42" x="466.181,473.891,477.741,479.931,482.121,485.971,490.241,494.511,499.301,504.301,509.301,514.201,516.391,520.771,526.291" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M130.450 385.300 L158.190 385.300 "/>
  <g begin="text">
   <text y="77.103" x="49.606,54.016,56.428,60.838,64.744,67.651,70.486,74.896,77.308,81.214,85.624,90.034,94.444,97.855,101.761,105.172,108.007,112.417,116.827,119.662,122.074,126.484,130.39,132.802,137.212,141.622,144.034,148.444,152.854,155.689,163.6,168.514,171.349,175.759,178.666,181.501,185.407,189.817,194.227,196.639,201.049,204.955,207.862,210.697,214.603,219.013,221.425,225.835,228.247,235.159,242.071,246.481,250.891,254.797,257.632,262.042,264.454,267.865,271.771,275.677,279.088,282.994,285.244" svgx:width="0.5,0.28,0.5,0.44,0.33,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.89,0.56,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">other diagnoses no including MS or another autoimmune disease. </text>
   <text y="88.101" x="49.606,55.015,59.425,63.331,66.256,69.667,73.573,80.485,84.895,87.307,91.213,94.624,96.874,97.549,99.961,104.371,106.621,107.296,109.708,114.118,118.024,120.949,123.361,127.267,131.677,136.087,138.994,142.9,145.312,149.722,152.629,157.039,159.289,159.964,162.871,167.281,169.693,172.105,176.515,182.923,185.335,189.745,194.155,196.405,197.08,200.491,202.903,206.809,211.219,215.629,219.535,222.442,226.852,229.264,233.17,237.076,241.486,243.736,244.411,248.821,251.728,256.138,260.044,263.95,268.36,272.77,275.677,279.583,282.994,285.244" svgx:width="0.61,0.5,0.44,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.5,0.44,0.33,0.5,0.28,0.44,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.5,0.5,0.33,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The samples in the laboratory following standardized procedures. </text>
   <text y="99.099" x="49.606,55.015,59.425,63.331,64.978,69.388,71.8,76.21,80.62,85.03,86.677,89.089,92.5,94.147,97.558,101.464,105.874,109.78,112.687,116.593,119.005,122.911,127.321,128.968,132.874,137.284,141.694,143.341,146.752,149.164,153.574,156.481,160.387,164.797,166.444,170.35,172.762,174.409,177.316,181.726,186.136,187.783,190.69,192.337,198.25,200.41,201.895,207.304,211.714,215.62,217.267,223.675,230.083,235.996,237.643,244.051,247.957,251.368,253.015,256.921,261.331,263.743,266.65,270.556,274.462,276.874,280.78,285.28" svgx:width="0.61,0.5,0.44,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.28,0.39,0.25,0.39,0.44,0.5,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.28,0.5,0.33,0.44,0.5,0.25,0.44,0.28,0.25,0.33,0.5,0.5,0.25,0.33,0.25,0.67,0.25,0.25,0.61,0.5,0.44,0.25,0.72,0.72,0.72,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The blood is separated and stored at -70 ˚ C. The DNA was extracted </text>
   <text y="110.097" x="49.606,52.513,55.42,59.83,66.742,69.073,71.485,75.895,79.801,82.132,86.542,90.448,92.86,95.272,99.178,101.59,103.921,108.331,111.238,113.569,115.981,119.887,124.297,128.203,132.613,136.519,140.929,143.341,147.247,150.658,152.989,156.895,161.305,163.717,166.624,170.53,174.436,176.848,180.754,185.164,187.495,193.903,196.315,198.727,203.137,204.973,211.381,217.294,223.702,226.033,229.939,233.35,235.681,239.587,243.997,246.409,248.821,252.727,257.137,261.043,265.453,269.863,272.275,276.181,280.591,283.003,285.253" svgx:width="0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.44,0.5,0.44,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.67,0.72,0.25,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.44,0.5,0.44,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">from the pellet of leucocytes extracted with ACD as anticoagulant. </text>
   <text y="121.095" x="49.606,55.015,59.425,63.331,65.581,67.723,74.131,80.539,86.452,88.702,90.844,94.75,99.16,101.572,104.479,108.385,112.291,114.703,118.609,123.019,125.269,127.411,131.821,136.231,138.481,140.623,143.035,147.445,151.351,153.601,155.743,158.155,162.061,165.967,170.377,174.787,177.199,181.609,186.019,189.925,192.175,194.317,198.727,201.634,203.884,206.026,212.938,217.348,221.758,224.17,227.077,229.489,233.395,237.805,240.055,242.197,248.11,252.52,256.93,260.836,263.743,266.65,271.06,275.47,277.882,281.788,285.289" svgx:width="0.61,0.5,0.44,0.25,0.55,0.72,0.72,0.72,0.25,0.55,0.44,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.5,0.5,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.67,0.5,0.5,0.44,0.33,0.33,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The DNA extracted by the technique of modified Covarrubias </text>
   <text y="132.093" x="49.606,55.519,59.929,63.835,68.245,72.151,75.562,77.812,78.514,84.427,88.837,91.582,94.489,98.899,103.309,107.215,109.465,110.167,114.073,118.483,122.893,125.143,125.845,132.253,136.159,139.066,141.478,143.89,148.3,152.71,155.122,159.532,163.942,166.354,168.604,169.306,177.217,179.629,182.041,184.453,188.359,191.266,193.516,194.218,198.124,202.534,206.944,209.194,209.896,214.81,217.222,221.128,224.539,228.949,233.359,235.771,238.021,238.723,246.634,250.54,254.95,257.362,261.268,263.68,266.092,269.503,271.753,272.455,276.361,280.771,285.271" svgx:width="0.67,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.67,0.5,0.33,0.33,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.28,0.25,0.55,0.89,0.28,0.28,0.28,0.44,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.56,0.28,0.44,0.39,0.5,0.5,0.28,0.25,0.55,0.89,0.44,0.5,0.28,0.44,0.28,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Cuevas Buffone and Darlington; Millar and Plesky; Maniatis and </text>
   <text y="143.091" x="49.606,54.52,57.427,59.839,62.251,65.662,69.568,73.978,76.138,77.461,83.869,86.776,89.188,93.094,96.001,102.409,106.315,109.222,113.632,117.043,118.861,123.271,127.681,132.091,134.998,137.41,141.82,144.232,148.138,152.044,154.456,156.868,161.278,165.688,167.506,173.914,177.82,181.231,183.049,187.459,191.365,194.272,197.179,201.589,204.496,211.408,215.314,219.724,221.542,225.952,230.362,232.18,236.086,240.496,244.906,247.318,251.728,256.138,257.956,260.368,264.778,268.684,270.502,273.913,278.323,282.229" svgx:width="0.56,0.33,0.28,0.28,0.39,0.44,0.5,0.25,0.25,0.72,0.33,0.28,0.44,0.33,0.72,0.44,0.33,0.5,0.39,0.25,0.5,0.5,0.5,0.33,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fritsch. Afterwards hybridization was performed by adding the spe-</text>
   <text y="154.089" x="49.606,53.512,55.924,58.831,61.243,65.149,67.84,72.754,78.667,84.58,87.271,91.681,94.588,98.998,103.408,107.818,111.724,114.136,116.827,119.734,124.144,127.051,129.742,133.648,137.554,141.46,145.87,148.561,150.973,155.383,159.289,163.699,167.11,169.801,172.213,176.623,179.314,181.726,186.136,190.546,194.452,197.863,200.275,202.687,207.097,211.003,213.415,217.321,219.481,222.172,227.581,231.487,233.899,237.805,240.712,243.403,245.815,250.225,254.131,256.822,260.233,264.139,271.051,275.461,277.873,281.779,285.28" svgx:width="0.44,0.28,0.33,0.28,0.44,0.25,0.56,0.67,0.67,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.25,0.33,0.5,0.33,0.25,0.44,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.25,0.61,0.44,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cific PCR product for each locus to investigate. Later the samples </text>
   <text y="165.087" x="49.606,53.512,57.418,61.828,66.238,68.65,71.557,75.463,79.873,82.033,88.441,90.853,93.265,97.675,99.835,104.749,107.161,111.571,115.981,118.888,123.298,127.204,131.614,135.52,137.932,142.342,146.248,150.154,153.061,155.221,160.63,165.04,171.952,174.364,178.774,182.68,187.09,189.25,196.0" svgx:width="0.44,0.44,0.5,0.5,0.28,0.33,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.56,0.28,0.5,0.5,0.33,0.5,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.33,0.25,0.61,0.5,0.78,0.28,0.5,0.44,0.5,0.25,0.76,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">acquired with Fluoroanalyzer Luminex ®.</text>
   <text y="176.085" x="49.606,56.104,60.1,63.601,68.605,71.107,74.104,77.605,80.602" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="176.085" x="82.996,87.496,91.996,94.39,100.888,104.884,109.384,112.381,116.881,123.883,128.383,132.379,134.881,137.383,139.885,142.387,145.888,148.282,154.78,159.28,161.782,164.284,168.28,172.276,174.67,179.17,183.166,185.668,188.17,192.166,196.666,199.168,202.669,205.063,209.059,213.559,218.059,220.453,224.953,229.453,233.953,236.347,240.343,244.843,249.343,251.845,254.842,259.342,261.844,265.345,267.739,274.237,278.233,281.23,285.226" svgx:width="0.5,0.5,0.25,0.72,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.72,0.5,0.28,0.28,0.44,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">63 Neuromyelitis Optica patients and 198 controls were </text>
   <text y="187.083" x="49.606,53.602,60.604,65.104,67.606,71.602,76.102,78.352,80.908,86.407,90.907,94.903,97.621,101.617,106.117,110.113,113.11,117.106,121.606,125.602,128.32,132.316,136.816,140.812,143.53,150.028,154.024,157.525,160.243,164.743,169.243,171.493,175.993,178.711,183.211,187.207,191.203,194.2,197.701,200.419,203.416,207.916,212.416,215.413,219.913,224.413,227.131,230.128,232.846,236.842,241.342,245.842,248.56,253.06,257.56,265.057,267.775,274.273,278.269,281.266,285.262" svgx:width="0.44,0.78,0.5,0.28,0.44,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.5,0.44,0.33,0.44,0.5,0.44,0.25,0.44,0.5,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.33,0.5,0.5,0.33,0.5,0.5,0.25,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.83,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ampled. The average age was 43.3 years (20-67 ) and 82% were </text>
   <text y="198.081" x="49.606,56.104,60.604,67.606,71.602,76.102" svgx:width="0.72,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">women.</text>
   <text y="209.079" x="61.603,68.101,73.6,79.603,81.934,88.432,94.435,98.935,103.435,105.766,112.264,116.26,119.761,122.092,126.592,129.589,133.585,137.086,141.082,145.582,148.084,150.415,152.917,157.417,159.748,164.248,166.579,170.575,174.571,178.072,182.068,185.569,187.9,190.897,195.397,197.647,202.147,206.647,214.144,217.141,219.472,223.468,227.968,232.468,234.799,239.299,243.799,246.301,250.801,253.132,255.634,260.134,262.465,266.965,269.296,273.292,277.792,282.292" svgx:width="0.72,0.61,0.72,0.25,0.72,0.67,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.25,0.44,0.44,0.39,0.44,0.39,0.25,0.33,0.5,0.25,0.5,0.5,0.83,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">HLA DR10 was present in 5 cases (0.08%) and only in 1 con-</text>
   <text y="220.077" x="49.606,52.108,55.105,59.605,62.107,64.357,67.354,71.854,74.104,78.604,83.104,87.604,95.101,98.098,100.348,102.598,109.096,111.598,114.1,118.6,120.85,124.846,127.096,131.596,134.098,138.598,140.848,145.348,149.848,154.348,156.598,158.848,165.346,171.349,173.599,178.099,182.599,184.849,189.349" svgx:width="0.28,0.33,0.5,0.28,0.25,0.33,0.5,0.25,0.5,0.5,0.5,0.83,0.33,0.25,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.72,0.67,0.25,0.5,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">trol (0.005%), with a p:0.001, OR 19.3.</text>
   <text y="231.075" x="49.606,56.104,60.604,65.608,69.604,72.106,77.11,80.611,83.113,87.613,92.617,96.118,99.115" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="231.075" x="101.077,104.074,108.574,110.536,115.036,119.536,122.533,124.495,127.996,130.498,134.998,139.498,143.998,145.96,152.458,157.957,164.455,170.953,176.956,181.456,185.956,187.918,190.42,193.921,195.883,202.885,207.385,210.382,214.378,216.34,219.337,222.334,226.33,230.83,235.33,239.326,243.826,246.328,248.29,250.792,255.292,257.254,261.754,265.75,268.252,270.754,274.75,279.25,281.752,285.253" svgx:width="0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.61,0.72,0.72,0.67,0.5,0.5,0.25,0.28,0.39,0.25,0.78,0.5,0.33,0.44,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In our study HLADR10 is more frequent in patients </text>
   <text y="242.073" x="49.606,56.104,58.606,61.108,65.608,67.975,74.473,78.469,82.969,85.471,89.467,91.969,95.47,97.837,102.337,104.839,108.34,112.336,116.332,119.833,123.829,126.196,128.698,133.198,137.194,141.694,144.061,146.563,151.063,153.43,157.426,161.926,166.426,168.928,171.925,176.425,178.927,182.428,184.795,191.293,193.795,196.297,200.797,203.164,206.665,209.167,213.163,215.665,218.167,221.668,224.17,226.672,230.668,234.664,237.166,239.533,243.034,245.536,250.036,254.536,257.038,260.035,262.537,266.533,270.529,275.029,279.025,283.021,285.271" svgx:width="0.72,0.28,0.28,0.5,0.25,0.72,0.44,0.5,0.28,0.44,0.33,0.39,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with Devic’s disease than in controls with statistical significance, </text>
   <text y="253.071" x="49.606,56.104,60.604,63.106,67.102,71.602,73.852,76.57,79.072,82.573,84.823,87.541,90.538,94.534,97.036,101.032,105.532,109.528,114.028,116.53,118.78,121.498,124.999,127.501,132.001,135.997,139.993,142.243,144.961,147.463,151.963,155.959,158.209,160.927,165.427,169.423,173.923,176.425,180.925,183.427,187.927,192.427,196.423,198.673,201.391,207.889,213.892,219.895,224.395,226.645,229.363,233.863,237.859,242.359,246.355,248.605,251.323,255.823,259.819,263.32,265.57,268.288,272.788,276.784,280.78,285.28" svgx:width="0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.55,0.39,0.28,0.5,0.44,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.25,0.55,0.72,0.67,0.67,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">which is relevant since the haplotype DRB1 gene has been </text>
   <text y="264.069" x="49.606,54.106,58.102,61.603,65.599,68.596,71.098,75.598,79.594,84.094,86.317,90.313,93.814,96.037,100.537,105.037,109.537,112.534,118.537,122.533,127.033,131.029,135.025,138.526,141.028,145.024,149.524,151.747,155.248,159.748,161.971,168.973,172.969,177.469,179.692,183.688,188.188,192.688,195.685,199.681,202.678,204.901,208.897,211.12,214.117,216.619,220.12,224.62,226.843,229.84,233.836,237.832,240.334,244.834,247.831,250.054,253.051,257.551,260.548,262.771,267.271,271.267,275.767,279.763,282.265" svgx:width="0.5,0.44,0.39,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.5,0.5,0.5,0.33,0.67,0.44,0.5,0.44,0.44,0.39,0.28,0.44,0.5,0.25,0.39,0.5,0.25,0.78,0.44,0.5,0.25,0.44,0.5,0.5,0.33,0.44,0.33,0.25,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">described as non-Caucasian so may confer a risk factor for devel-</text>
   <text y="275.067" x="49.606,54.106,58.606,61.108,65.608,70.108,72.358,74.563,79.063,83.563,86.065,88.567,92.563,94.813,97.018,101.518,105.514,110.014,113.011,117.511,124.513,129.013,133.009,135.511,138.013,140.515,143.017,146.518,148.768,150.973,153.475,157.975,160.225,162.43,166.93,171.43,174.427,176.677,178.882,183.382,187.882,192.382,196.882,199.384,203.38,205.882,208.384,212.884,217.384,219.634,221.884,224.089,229.588,234.088,238.084,242.584,244.834,247.039,254.041,258.541,261.538,265.534,267.784,270.034,272.239,274.741,279.241,281.743,285.244" svgx:width="0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.5,0.25,0.55,0.78,0.5,0.33,0.44,0.25,0.25,0.55,0.28,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">oping optic neuromyelitis in our population. Even more, this </text>
   <text y="286.065" x="49.606,53.602,56.104,58.606,62.602,65.104,69.1,71.35,72.286,76.786,80.782,84.283,86.533,87.469,91.969,95.965,99.961,104.461,106.711,107.647,112.147,116.143,119.644,123.64,126.637,129.139,133.639,137.635,142.135,144.385,145.321,147.823,152.323,154.573,155.509,160.009,162.511,167.011,171.007,174.004,176.254,177.19,181.186,185.686,188.188,192.688,195.19,202.192,209.194,213.694,218.194,222.19,224.44,225.376,229.876,232.378,235.879,239.875,243.871,247.372,251.368,254.869,257.119,258.055,261.556,266.056,270.052,274.552,276.802,277.738,281.734,285.235" svgx:width="0.44,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">allele has been described in other autoimmune diseases such as </text>
   <text y="297.063" x="49.606,52.603,57.103,61.099,65.599,72.601,76.597,79.099,83.599,86.101,90.601,92.851,93.886,97.882,100.879,103.381,107.881,110.878,113.38,115.882,118.384,121.885,124.135,125.17,129.166,133.666,138.166,140.416,141.451,143.953,146.455,148.705,149.74,153.241,157.237,161.233,168.235,171.736,173.986,175.021,177.523,182.023,184.273,185.308,189.808,193.804,196.054,197.089,201.589,204.586,209.086,211.588,215.584,219.58,222.082,224.584,229.084,233.08,235.33,236.365,239.362,243.862,246.859,249.109,250.144,258.145,263.149,265.399,266.434,268.936,273.436,275.686,276.721,280.717,285.217" svgx:width="0.33,0.5,0.44,0.5,0.78,0.44,0.28,0.5,0.28,0.5,0.25,0.55,0.44,0.33,0.28,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.28,0.25,0.55,0.39,0.44,0.44,0.78,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rheumatoid arthritis and it seems to be protective for MS in an </text>
   <text y="308.061" x="49.606,53.107,57.607,61.603,66.103,68.605,72.106,76.606,78.856,82.357,84.859,89.359,93.859,98.359,100.609,107.107,111.607,115.603,120.103,122.353,124.855,127.357,130.858,133.108,137.104,141.604,148.606,153.106,155.608,160.108,164.104,168.604,170.854,177.352,179.854,182.356,186.856,189.106,195.604,201.103,207.106,209.356,215.854,221.857,227.86,232.36,236.86,241.36,245.86" svgx:width="0.39,0.5,0.44,0.5,0.28,0.39,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.5,0.44,0.5,0.25,0.28,0.28,0.39,0.25,0.44,0.5,0.78,0.5,0.28,0.5,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.61,0.72,0.25,0.72,0.67,0.67,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">spanish study when its combined with HLA DRB1*15.</text>
   <text y="340.065" x="49.606,55.105,59.605,64.105" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P647</text>
   <text y="351.063" x="49.606,55.609,60.613,64.609,66.859,71.863,74.365,78.865,82.366,89.863,94.363,96.613,101.113,106.117,109.114,111.616,116.116,121.12,126.124,130.624,135.628,140.128,144.124,146.626,151.63,153.88,158.38,163.384,166.381,168.883,173.887,178.387,183.391,185.893,189.889,193.39,195.64,200.14,205.144,210.148,212.398,215.395,220.399,224.395,226.645,231.145,236.149,239.146,243.142,247.642,255.139,259.135" svgx:width="0.67,0.56,0.44,0.25,0.56,0.28,0.5,0.39,0.83,0.5,0.25,0.5,0.56,0.33,0.28,0.5,0.56,0.56,0.5,0.56,0.5,0.44,0.28,0.56,0.25,0.5,0.56,0.33,0.28,0.56,0.5,0.56,0.28,0.44,0.39,0.25,0.5,0.56,0.56,0.25,0.33,0.56,0.44,0.25,0.5,0.56,0.33,0.44,0.5,0.83,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">The plasma antiaquaporin antibodies and the outcome </text>
   <text y="362.061" x="49.606,54.106,57.103,59.353,66.85,71.35,75.346,77.848,80.35,83.347,85.849,89.35,91.6,94.102,99.106,101.356,106.36,110.356,115.36,119.356,123.856,131.353,135.853,139.849,142.351,144.853,147.85,150.352,153.853,156.103,160.603,165.607,168.604,171.106,175.102,179.602,181.852,186.352,191.356,196.36,198.61,203.614,207.61,212.614,216.61,221.11,228.607,233.107,237.103,239.605,242.107,245.104,247.606,251.107" svgx:width="0.5,0.33,0.25,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.28,0.56,0.25,0.56,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.5,0.56,0.33,0.28,0.44,0.5,0.25,0.5,0.56,0.56,0.25,0.56,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">of myelitis in neuromyelitis optica and neuromyelitis </text>
   <text y="373.059" x="49.606,54.106,59.11,62.107,64.609,68.605,73.105,75.355,78.856,83.86,87.856,91.852,94.849,98.845,103.849,111.346,113.596,118.6,121.102,124.603,129.103,133.099,138.103,142.099,146.095,149.596,152.593,154.843,159.343,164.347,168.847,171.097,175.093,179.089,181.591,186.091,189.088,191.59,196.09,201.094,204.595,209.599,212.101,217.105" svgx:width="0.5,0.56,0.33,0.28,0.44,0.5,0.25,0.39,0.56,0.44,0.44,0.33,0.44,0.56,0.83,0.25,0.56,0.28,0.39,0.5,0.44,0.56,0.44,0.44,0.39,0.33,0.25,0.5,0.56,0.5,0.25,0.44,0.44,0.28,0.5,0.33,0.28,0.5,0.56,0.39,0.56,0.28,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">optica spectrum disorders: any relationship?</text>
   <text y="384.057" x="49.606,55.105,57.355,60.352,64.852,67.354,74.356,78.352" svgx:width="0.61,0.25,0.33,0.5,0.28,0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">E Idiman</text>
   <text y="381.583" x="82.852" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="384.103" x="85.777,88.027,90.277,95.281,97.531,100.528,105.028,107.53,114.532,118.528" svgx:width="0.25,0.25,0.56,0.25,0.33,0.5,0.28,0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Idiman</text>
   <text y="381.583" x="123.028" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="384.103" x="125.953,128.203,130.453,136.951,139.201,145.699,149.695,154.195" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Kaya</text>
   <text y="381.583" x="158.19" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="384.103" x="161.115,163.365,165.615,170.619,172.869,178.872,182.868,187.368,189.87" svgx:width="0.25,0.25,0.56,0.25,0.67,0.44,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Cevik</text>
   <text y="381.583" x="194.37" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="384.103" x="197.295,199.545,201.795,207.294,209.544,216.042,218.544,221.046,225.546" svgx:width="0.25,0.25,0.61,0.25,0.72,0.28,0.28,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, Z Altun</text>
   <text y="381.583" x="230.046" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="392.581" x="49.609" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="395.103" x="52.531,59.029,63.529,67.525,72.025,75.526,77.776,83.275,87.271,89.773,94.273,96.775,99.025,105.523,110.023,112.525,116.521,120.517,124.018,127.519,130.021,132.523,136.519,138.769,141.019,147.022,151.018,155.518,159.019,163.519,166.021,170.521,175.021,179.017,181.267,183.517,186.514,190.015,196.513,199.015,202.516,204.766,207.016,212.02,216.52,220.021,224.017,228.013,232.009,234.259" svgx:width="0.72,0.5,0.44,0.5,0.39,0.25,0.61,0.44,0.28,0.5,0.28,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.33,0.39,0.72,0.28,0.39,0.25,0.25,0.56,0.5,0.39,0.44,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Dokuz Eylul University, Neurology, Izmir, Turkey, </text>
   <text y="392.583" x="236.507" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="395.103" x="239.432,245.93,250.43,254.426,258.926,262.427,264.677,270.176,274.172,276.674,281.174,283.676" svgx:width="0.72,0.5,0.44,0.5,0.39,0.25,0.61,0.44,0.28,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Dokuz Eylul </text>
   <text y="406.101" x="49.604,56.102,60.602,63.104,67.1,71.096,74.597,78.098,80.6,83.102,87.098,89.348,91.598,94.595,98.096,104.594,107.096,110.597,112.847,115.097,120.101,124.601,128.102,132.098,136.094,140.09,142.34" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.33,0.39,0.72,0.28,0.39,0.25,0.25,0.56,0.5,0.39,0.44,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University, Izmir, Turkey, </text>
   <text y="403.583" x="144.591" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="406.103" x="147.516,154.014,158.514,162.51,167.01,170.511,172.761,178.26,182.256,184.758,189.258,191.76,194.01,200.508,205.008,207.51,211.506,215.502,219.003,222.504,225.006,227.508,231.504,233.754,236.004,242.502,247.002,250.998,255.498,258.0,262.5,267.0,270.996,273.246" svgx:width="0.72,0.5,0.44,0.5,0.39,0.25,0.61,0.44,0.28,0.5,0.28,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.72,0.5,0.44,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Dokuz Eylul University, Oncology, </text>
   <text y="417.101" x="49.605,52.602,56.103,62.601,65.103,68.604,70.854,73.104,78.108,82.608,86.109,90.105,94.101" svgx:width="0.33,0.39,0.72,0.28,0.39,0.25,0.25,0.56,0.5,0.39,0.44,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Izmir, Turkey</text>
   <text y="444.101" x="49.605,55.608,60.108,64.104,69.108,73.608,77.442,81.942,86.946,91.95,96.954,99.951" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="444.101" x="103.668,108.672,113.172,120.174,124.17,126.42,127.887,132.387,136.383,138.885,141.387,145.383,149.883,152.385,155.886,158.136,159.603,166.101,168.603,171.105,175.605,177.855,179.322,183.822,187.818,192.318,195.315,199.815,206.817,211.317,215.313,217.815,220.317,222.819,225.321,228.822,231.072,232.539,237.039,241.539,244.041,246.543,250.539,254.535,256.78499999999997,258.252,261.249,267.747,275.748,282.246,285.243" svgx:width="0.56,0.5,0.78,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.44,0.25,0.55,0.33,0.72,0.89,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Some patients with neuromyelitis optica (NMO) </text>
   <text y="455.099" x="49.605,53.601,58.101,62.601,64.437,70.935,78.936,85.434,87.27,90.771,95.271,99.267,103.263,105.765,108.762,113.262,120.264,122.1,126.6,129.102,132.603,137.103,140.1,144.6,148.596,151.593,155.094,156.93,159.927,166.425,174.426,180.924,185.928,192.426,195.423,197.259,201.759,205.755,210.255,214.251,216.087,219.588,222.09,229.092,231.594,234.096,238.092,241.089,242.925,246.921,249.423,251.925,256.425,258.927,262.923,266.919,269.421,271.257,274.254,278.25,282.246" svgx:width="0.44,0.5,0.5,0.25,0.72,0.89,0.72,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.5,0.78,0.25,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.33,0.72,0.89,0.72,0.56,0.72,0.33,0.25,0.5,0.44,0.5,0.44,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and NMO spectrum disorders (NMOSD) have similar clinical fea-</text>
   <text y="466.097" x="49.605,52.107,56.607,59.604,63.6,67.101,69.351,70.557,75.057,79.557,81.807,83.013,87.513,92.013,94.515,96.765,97.971,102.471,106.467,110.967,114.963,117.213,117.924,124.422,128.922,131.424,133.926,136.923,143.421,147.921,152.421,156.417,160.917,165.417,168.414,170.916,175.416,178.413,182.913,185.163,186.369,189.366,195.864,202.362,207.366,211.866,214.863,217.113,218.319,222.315,226.815,229.317,231.819,236.319,240.819,245.319,249.819,252.069,253.275,257.271,261.771,266.271,268.521,269.727,276.729,280.725,285.225" svgx:width="0.28,0.5,0.33,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.72,0.5,0.28,0.28,0.33,0.72,0.5,0.5,0.44,0.5,0.5,0.33,0.28,0.5,0.33,0.5,0.25,0.55,0.33,0.72,0.72,0.56,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tures do not have Anti-Aquaporin-4 (AQP4) antibody and may </text>
   <text y="477.095" x="49.605,54.105,58.101,62.601,66.597,69.099,73.095,75.597,80.097,82.599,85.434,88.431,92.427,95.424,99.42,103.92,106.422,108.924,112.92,117.42,121.92,126.42,128.922,131.424,133.926,138.426,142.926,145.428,151.926,154.428,156.93,161.43,163.932,168.432,170.934,173.769,176.766,180.762,183.759,187.755,192.255,194.757,197.259,201.759,206.259,208.761,212.757,217.257,224.259,228.255,231.756,234.258,240.756,243.258,245.76,250.26,252.762,255.759,259.755,264.255,268.251,271.248,275.748,278.25,280.752,285.252" svgx:width="0.5,0.44,0.5,0.44,0.25,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.5,0.44,0.33,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">have a different condition with different outcomes with regard to </text>
   <text y="488.093" x="49.605,56.607,61.107,63.609,68.109,71.106,73.356,77.856,80.358,83.859,87.855,92.355,94.857,97.359,99.861,102.363,106.278" svgx:width="0.78,0.5,0.28,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">motor disability.</text>
   <text y="499.091" x="49.605,56.607,61.611,64.608,68.604,72.6,75.597,78.099,82.599,86.595,90.096,93.093" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="499.091" x="95.406,100.275,104.775,107.088,111.588,115.584,118.086,122.082,125.079,132.081,134.583,139.083,143.079,145.392,151.89,156.39,160.386,162.888,167.388,171.384,174.381,176.694,179.196,183.696,187.692,189.51,196.008,202.506,207.51,212.01,214.323,218.319,222.819,225.321,227.823,232.323,236.823,241.323,245.823,248.136,252.636,256.632,260.133,262.446,266.442,268.755,271.752,275.748,278.25,282.246" svgx:width="0.61,0.5,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.72,0.72,0.56,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.39,0.25,0.44,0.25,0.33,0.44,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To determine whether the AQP4 antibody has a rela-</text>
   <text y="510.089" x="49.605,52.107,54.609,59.109,63.609,67.11,71.61,74.112,78.612,80.862,82.743,89.241,91.743,94.245,98.745,100.995,102.876,105.378,109.878,113.874,116.124,118.005,122.505,125.502,130.002,134.502,139.002,143.502,147.003,149.505,153.006,155.256,157.137,161.637,164.634,166.884,168.765,171.267,174.264,178.26,182.76,186.261,190.761,194.757,197.754,201.255,205.251,207.501,209.382,216.384,220.884,224.88,227.382,229.884,232.386,234.888,238.389,240.639,242.52,245.022,249.522,251.772,253.653,256.155,260.151,263.148,270.15,273.651,275.901,277.782,282.282,285.279" svgx:width="0.28,0.28,0.5,0.5,0.39,0.5,0.28,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.5,0.44,0.33,0.39,0.44,0.25,0.55,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.44,0.33,0.78,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tionship with the prognosis of transverse myelitis in terms of </text>
   <text y="521.087" x="49.605,56.607,61.107,63.609,68.109,71.106,73.356,77.856,80.358,83.859,87.855,92.355,94.857,97.359,99.861,102.363,106.278" svgx:width="0.78,0.5,0.28,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">motor disability.</text>
   <text y="532.085" x="49.605,58.101,62.097,65.094,70.098,74.598,79.602,83.103,86.1" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="532.085" x="89.61,94.614,98.61,101.607,105.603,107.853,109.113,113.613,116.61,118.86,120.12,124.62,129.12,131.37,132.63,137.13,141.126,143.628,146.13,150.126,154.626,157.128,160.629,162.879,164.139,170.637,173.139,175.641,180.141,182.391,183.651,190.149,198.15,204.648,206.898,208.158,211.155,215.655,220.731,225.231,229.731,232.728,234.978,236.238,240.234,244.734,249.234,251.484,252.744,259.242,267.243,273.741,278.745,285.243" svgx:width="0.56,0.44,0.33,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.89,0.72,0.56,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Sera of 34 patients with NMO (n=27) and NMOSD </text>
   <text y="543.083" x="49.605,56.103,58.605,61.107,65.607,68.064,70.566,74.067,78.567,81.069,85.065,87.567,91.563,96.063,98.52,103.02,106.017,108.474,111.471,115.467,119.463,123.963,126.96,129.957,133.953,138.453,140.955,143.412,150.414,154.914,158.91,161.412,163.914,166.416,168.918,172.419,174.876,177.873,182.373,187.449,191.949,194.946,197.403,203.901,207.897,210.894,214.89,217.347,221.343,223.845,226.347,228.804,231.306,235.806,240.306,244.302,247.803,250.305,252.807,257.307,261.303,263.805,267.801,272.301,274.758,277.755,282.255,285.252" svgx:width="0.72,0.28,0.28,0.5,0.25,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.33,0.25,0.33,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.33,0.5,0.56,0.5,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.28,0.28,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with isolated or recurrent myelitis (n=7) were all investigated for </text>
   <text y="554.081" x="49.605,52.107,56.607,60.603,63.069,67.569,70.566,74.562,78.063,82.059,86.559,90.555,94.551,97.017,101.517,104.514,106.485,112.983,119.481,124.485,128.985,131.451,135.447,139.947,142.449,144.951,149.451,153.951,158.451,162.951,165.417,169.917,174.417,176.883,180.879,183.345,187.341,191.337,193.839,196.341,199.338,203.838,207.834,211.335,215.331,219.831,222.297,224.799,229.299,233.799,236.301,239.298,243.294,247.29,249.792,252.258,254.76,261.762,268.764,273.264,277.764,282.264" svgx:width="0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.72,0.72,0.56,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.25,0.44,0.25,0.44,0.44,0.28,0.28,0.33,0.5,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the presence of AQP4 antibody by a cell-based indirect immuno-</text>
   <text y="565.079" x="49.605,52.602,55.104,59.604,64.104,67.101,71.097,74.598,78.594,82.59,87.09,91.086,95.082,97.332,98.547,102.543,106.044,109.545,113.541,118.041,120.291,121.515,124.512,127.509,130.506,134.844,141.342,144.339,146.589,148.839,149.901,155.4,159.9,163.896,166.146,167.361,171.861,174.858,179.358,183.858,188.358,192.858,196.359,198.861,201.363,205.359,207.609,208.833,213.333,217.329,219.831,224.331,228.327,231.828,234.078,235.293,239.793,242.79,245.04,246.264,250.26,254.76,257.262,259.764,262.761,269.259,275.757,280.761,285.261" svgx:width="0.33,0.28,0.5,0.5,0.33,0.44,0.39,0.44,0.44,0.5,0.44,0.44,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.33,0.33,0.33,0.56,0.72,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.55,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fluorescence assay (IIFA). The prognostic values of anti-AQP4 </text>
   <text y="576.077" x="49.605,53.601,58.101,60.603,63.105,67.605,72.105,76.605,81.105,83.625,90.123,94.119,97.116,101.112,103.632,107.628,112.128,116.124,118.626,123.126,127.122,129.624,133.62,138.12,140.64,143.142,147.642,150.162,152.664,156.66,159.657,166.659,170.16,172.68,177.18,180.177,182.697,186.693,189.213,193.713,198.213,202.713,207.213,209.733,216.735,221.235,223.737,228.237,231.234,233.754,238.254,242.754,245.256,249.252,253.752,260.754,264.75,267.27,270.267,274.263,278.763,281.265,285.261" svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.44,0.33,0.78,0.39,0.25,0.5,0.33,0.25,0.44,0.25,0.5,0.5,0.5,0.5,0.25,0.78,0.5,0.28,0.5,0.33,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.33,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antibody were evaluated in terms of a good motor outcome (able </text>
   <text y="587.075" x="49.605,52.107,56.607,58.497,64.995,68.991,71.493,75.993,77.883,82.383,86.883,90.879,93.381,97.881,101.877,106.377,108.267,111.264,115.764,118.761,120.651,124.647,127.149,129.039,131.541,135.537,139.533,143.034,145.536,147.426,151.926,156.426,160.926,162.816,169.818,173.814,176.316,179.313,183.309,186.81,189.807,191.697,195.693,200.193,204.693,206.583,210.579,212.469,216.969,221.469,225.969,228.966,230.856,237.858,242.358,244.86,249.36,252.357,254.247,258.747,263.247,265.749,269.745,274.245,281.247,285.243" svgx:width="0.28,0.5,0.25,0.72,0.44,0.28,0.5,0.25,0.5,0.5,0.44,0.28,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.5,0.5,0.25,0.78,0.44,0.28,0.33,0.44,0.39,0.33,0.25,0.44,0.5,0.5,0.25,0.44,0.25,0.5,0.5,0.5,0.33,0.25,0.78,0.5,0.28,0.5,0.33,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to walk unaided for at least 100 metres) and a poor motor outcome </text>
   <text y="598.073" x="49.605,52.602,59.1,61.602,64.104,68.604,70.854,74.85,77.352,81.852,84.102,86.604,91.104,93.354,99.852,103.848,106.35,110.85,113.1,117.096,119.598,121.848,124.35,128.346,132.342,135.843,138.345,140.595,145.095,149.595,154.095,156.345,163.347,167.343,169.845,172.842,176.838,180.339,182.589,187.089,190.086,192.336,196.332,198.582,205.08,209.58,212.577,216.078,220.074,222.324,226.32,230.82,235.32,239.82,242.322,244.824,247.326,251.826,256.326,259.323" svgx:width="0.33,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.5,0.25,0.28,0.5,0.25,0.72,0.44,0.28,0.5,0.25,0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.5,0.5,0.25,0.78,0.44,0.28,0.33,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.25,0.72,0.5,0.33,0.39,0.44,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(with aid to walk at least 100 metres or a worse condition).</text>
   <text y="609.071" x="49.605,56.103,60.099,63.6,68.604,71.106,74.103,77.604,80.601" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="609.071" x="83.103,86.1,90.6,93.102,97.602,102.102,105.099,107.601,111.102,113.604,118.104,122.604,126.519,128.769,131.271,133.773,138.273,142.269,144.771,148.767,153.267,155.769,158.271,161.268,167.766,174.264,179.268,183.768,186.27,190.266,194.766,197.268,199.77,204.27,208.77,213.27,217.77,220.767,224.268,226.77,230.271,234.267,237.264,241.764,246.264,250.764,254.265,256.767,259.269,261.771,266.271,268.773,271.275,275.775,278.277,280.779,285.279" svgx:width="0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.33,0.39,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In our study, the anti-AQP4 antibody´s seropositivity in </text>
   <text y="620.069" x="49.605,53.601,56.103,58.605,60.855,61.8,65.796,69.792,73.293,77.289,80.79,83.04,83.985,90.483,94.479,97.98,100.23,101.175,105.675,110.175,112.425,116.925,124.422,126.672,127.617,130.614,135.114,140.19,144.69,149.19,152.187,154.437,156.687,157.632,164.13,168.126,171.627,173.877,174.822,179.322,183.822,186.072,190.572,198.069,200.319,201.264,203.766,208.266,210.516,211.461,217.959,225.96,232.458,234.708,235.653,239.649,244.149,248.649,250.899,251.844,256.344,260.844,263.094,267.594,275.091,277.341,278.286,280.788,285.288" svgx:width="0.44,0.28,0.28,0.25,0.55,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">all cases was 61.8% (n=21), was 59.3% in NMO and 71.4% in </text>
   <text y="631.067" x="49.605,56.103,64.104,70.602,75.606,82.104,84.354,86.424,90.42,94.416,97.917,101.913,105.414,107.664,109.914,111.489,117.987,122.487,124.989,127.491,130.488,136.986,143.484,148.488,152.988,155.238,157.308,161.304,165.804,168.306,170.808,175.308,179.808,184.308,188.808,191.058,193.128,196.629,200.625,203.622,208.122,212.622,217.122,220.623,223.125,225.627,228.129,232.629,235.131,237.633,241.629,245.13,247.38,249.45,253.95,257.946,262.446,264.696,266.766,271.266,273.768,278.268,282.264,285.261" svgx:width="0.72,0.89,0.72,0.56,0.72,0.25,0.55,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMOSD cases. Anti-AQP4 antibody seropositivites had older </text>
   <text y="642.065" x="49.605,54.105,56.607,60.108,64.104,68.1,71.601,75.597,78.261,82.761,87.261,90.762,94.758,97.26,99.924,102.921,107.421,111.921,116.862,121.362,125.862,128.112,132.612,135.276,139.776,143.277,145.941,150.441,154.941,157.191,161.691,166.632,171.132,173.382,177.882,180.132,182.796,187.296,192.372,196.872,199.122,203.622,208.122,212.622,215.619,217.869,220.038,226.536,231.036,235.536,238.2,242.7,247.2,249.45,253.95,261.447,264.111,268.611,271.608,274.272,276.774,281.274,285.27" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.33,0.5,0.5,0.55,0.5,0.5,0.25,0.5,0.25,0.5,0.39,0.25,0.5,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.25,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.72,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disease onset (39±13.5 vs 27.9±8.7, p=0.009). And 33.3% of the </text>
   <text y="653.063" x="49.605,53.106,57.102,60.099,64.599,69.099,73.599,77.1,79.602,82.104,84.606,89.106,93.102,95.208,99.708,103.704,106.206,108.708,112.704,117.204,119.706,123.207,125.313,129.309,133.809,138.309,140.415,144.915,149.415,151.665,156.165,163.662,165.768,170.268,173.265,175.371,177.873,182.373,186.369,188.475,191.976,195.972,198.969,203.469,207.969,211.965,216.465,220.461,222.963,225.465,229.965,233.961,236.067,240.567,244.563,247.065,249.567,253.563,258.063,260.565,264.066,266.172,270.672,274.668,279.168,281.274,285.27" svgx:width="0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">seropositive patients and 38.5% of the seronegative patients had a </text>
   <text y="664.061" x="49.605,54.105,58.605,63.105,66.102,68.352,70.449,77.451,81.951,84.453,88.953,91.95,94.2,96.297,100.797,103.299,106.8,110.796,115.296,117.798,120.3,122.802,125.304,129.219,131.469,133.719,135.816,140.316,144.816,147.813,150.315,154.815,159.315,161.565,163.662,167.658,169.908,172.005,175.002,179.502,182.004,184.506,189.006,195.504,198.501,203.001,207.501,209.751,211.848,216.348,220.344,223.341,225.843,230.343,234.843,237.093,239.19,243.69,246.687,248.937,251.034,255.534,260.034,264.534,269.475,273.975,278.475,280.725,285.225" svgx:width="0.5,0.5,0.5,0.33,0.25,0.55,0.78,0.5,0.28,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.55,0.5,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">poor motor disability, during a follow-up period of 102±79.1 </text>
   <text y="675.059" x="49.605,56.607,61.107,65.607,68.109,72.609,76.11,78.36,80.673,86.172,90.672,94.668,97.665,101.661,104.136,110.634,114.63,118.131,120.606,125.106,129.606,132.081,135.582,138.084,142.584,147.084,149.586,152.583,155.085,159.081,163.077,167.577,170.079,172.554,177.054,179.556,182.391,185.388,189.384,192.381,196.377,200.877,204.873,208.869,211.344,213.846,218.346,222.342,224.844,227.319,231.315,235.815,238.317,241.818,244.32,248.316,252.816,255.291,259.791,263.787,266.289,272.787,276.783,280.779,285.279" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.44,0.28,0.25,0.44,0.5,0.28,0.39,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months. There was no significant difference that existed between </text>
   <text y="686.057" x="49.605,53.601,58.101,60.603,63.105,66.102,72.6,79.098,84.102,88.602,90.852,91.914,95.91,100.41,102.912,105.414,109.914,114.414,118.914,123.414,125.664,126.726,130.227,134.223,137.22,141.72,146.22,150.72,154.221,156.723,159.225,161.727,166.227,168.729,171.231,175.731,177.981,179.043,183.039,187.539,192.039,194.289,195.351,198.852,202.848,205.845,210.345,214.845,218.841,223.341,227.337,229.839,232.341,236.841,240.837,243.087,244.149,246.651,251.151,253.401,254.463,256.965,260.961,263.958,270.96,274.461,276.711,277.773,282.273,285.27" svgx:width="0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.44,0.33,0.78,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">anti-AQP4 antibody seropositivity and seronegative in terms of </text>
   <text y="697.055" x="49.605,56.607,61.107,63.609,68.109,71.106,73.356,77.856,80.358,83.859,87.855,92.355,94.857,97.359,99.861,102.363,106.863,109.113,112.11,116.61,121.686,126.186,128.436,132.936,137.436,141.936,144.933" svgx:width="0.78,0.5,0.28,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">motor disability (p=0.770).</text>
   <text y="708.053" x="49.605,56.103,60.603,65.607,69.603,72.105,77.109,80.61,83.112,87.612,92.616,96.117,99.114" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="708.053" x="103.245,109.743,113.244,115.494,117.375,121.371,125.871,132.873,137.373,141.369,144.366,148.362,152.862,155.112,156.993,163.491,165.993,168.495,172.995,175.245,177.126,181.122,185.622,188.124,190.626,193.623,200.121,206.619,211.623,216.123,218.373,220.254,224.25,228.75,231.252,233.754,238.254,242.754,247.254,251.754,254.751,259.251,263.247,267.747,271.743,274.245,276.747,281.247,285.243" svgx:width="0.72,0.39,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">As compared with anti-AQP4 antibody-negative </text>
   <text y="719.051" x="49.605,54.105,58.605,62.601,66.102,68.352,70.602,72.933,76.929,81.429,83.931,86.433,89.43,95.928,102.426,107.43,111.93,114.18,116.511,120.507,125.007,127.509,130.011,134.511,139.011,143.511,148.011,151.008,155.508,160.008,163.509,166.011,168.513,171.015,175.515,179.511,181.761,184.092,188.592,192.588,195.09,197.592,201.588,206.088,208.59,212.091,214.341,216.672,220.173,224.673,229.173,235.671,237.921,240.252,243.753,246.255,250.755,255.255,257.757,260.754,263.256,267.252,271.248,275.748,278.25,280.752,285.252" svgx:width="0.5,0.5,0.44,0.39,0.25,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.72,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ones, anti-AQP4 antibody-positive patients show significantly </text>
   <text y="730.049" x="49.605,54.105,56.607,61.107,65.103,68.1,70.35,71.358,75.858,78.36,81.861,85.857,89.853,93.354,97.35,99.6,100.608,105.108,109.608,113.109,117.105,119.607,121.857,124.107,124.953,130.452,134.952,138.948,141.198,142.206,146.706,151.206,153.708,157.704,162.204,169.206,173.202,175.452,176.46,180.96,183.957,186.207,187.215,194.217,198.717,202.713,205.215,207.717,210.219,212.721,216.222,218.472,219.48,221.982,226.482,228.732,229.74,232.242,236.238,239.235,246.237,249.738,251.988,252.996,257.496,260.493,262.743,263.751,270.753,275.253,277.755,282.255,285.252" svgx:width="0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.28,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.44,0.33,0.78,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.5,0.28,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">older disease onset. The outcome of myelitis in terms of motor </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 138.300 L348.500 138.300 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 698.300 L335.000 698.300 "/>
  <g begin="text">
   <text y="77.103" x="297.26,301.76,304.262,307.763,311.759,316.259,318.761,321.263,323.765,326.267,330.767,333.017,334.358,340.856,344.852,348.353,350.603,351.944,355.445,357.947,364.949,367.451,369.953,373.949,376.946,379.196,380.537,383.039,387.539,389.789,391.13,395.63,400.13,402.632,407.132,409.382,410.723,414.719,419.219,421.721,424.223,427.22,433.718,440.216,445.22,449.72,451.97,453.311,457.307,461.807,464.309,466.811,471.311,475.811,480.311,484.811,487.808,492.308,496.808,500.309,502.811,505.313,507.815,512.315,516.311,518.561,519.902,523.898,528.398,532.898" svgx:width="0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disability was similar in both anti-AQP4 antibody-positive and </text>
   <text y="88.101" x="297.26,301.76,305.756,310.256,314.252,316.754,319.256,323.756,327.752,330.002,334.502,338.498,341.0,343.502,347.498,351.998,354.5,358.001" svgx:width="0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">negative patients.</text>
   <text y="115.101" x="297.26,302.759,307.259,311.759" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P648</text>
   <text y="126.099" x="297.26,303.758,308.762,311.759,316.259,320.759,325.763,328.76,331.262,336.266,340.766,345.77,348.272,352.268,355.769,358.019,360.521,365.525,367.775,372.779,377.279,380.276,382.778,386.774,391.778,394.775,398.276,400.526,407.024,409.526,412.523,417.527,419.777,424.781,428.777,433.781,437.777,442.277,449.774,454.274,458.27,460.772,463.274,466.271,468.773,472.274,474.524,479.024,484.028,487.025,489.527,493.523" svgx:width="0.72,0.56,0.33,0.5,0.5,0.56,0.33,0.28,0.56,0.5,0.56,0.28,0.44,0.39,0.25,0.28,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.72,0.28,0.33,0.56,0.25,0.56,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.5,0.56,0.33,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Autoantibodies in patients with neuromyelitis optica</text>
   <text y="137.097" x="297.26,305.756,311.255,317.258,320.759,323.009,328.013,332.009,335.006,339.002,341.504,344.501" svgx:width="0.94,0.61,0.67,0.39,0.25,0.56,0.44,0.33,0.44,0.28,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">WLCJ Pereira</text>
   <text y="134.583" x="348.496" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="137.103" x="351.421,353.671,355.921,362.419,367.423,369.673,376.171,380.167,382.669,385.171,389.167,393.667" svgx:width="0.25,0.25,0.72,0.56,0.25,0.72,0.44,0.28,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AP Kallaur</text>
   <text y="134.583" x="396.663" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="137.103" x="399.588,401.838,404.088,409.092,415.095,417.345,423.843,426.345,428.847,433.347,437.343,439.845,442.842" svgx:width="0.25,0.25,0.56,0.67,0.25,0.72,0.28,0.28,0.5,0.44,0.28,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, SR Oliveira</text>
   <text y="134.583" x="446.838" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="137.103" x="449.763,452.013,454.263,460.761,467.259,473.262,475.512,480.516,483.018,490.02,494.016" svgx:width="0.25,0.25,0.72,0.72,0.67,0.25,0.56,0.28,0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, ANC Simao</text>
   <text y="134.583" x="498.515" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="137.103" x="501.44,503.69" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="148.101" x="297.257,302.756,306.257,312.755,315.005,320.009,324.005,328.505,331.007,335.003,339.503,343.499" svgx:width="0.61,0.39,0.72,0.25,0.56,0.44,0.5,0.28,0.44,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LJV Schiavao</text>
   <text y="145.583" x="348.001" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="148.103" x="350.926,353.176,355.426,360.43,366.433,372.931,377.935,380.185,386.188,390.688,395.188,398.185,400.687,405.187,409.687,413.683" svgx:width="0.25,0.25,0.56,0.67,0.72,0.56,0.25,0.67,0.5,0.5,0.33,0.28,0.5,0.5,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, PRVP Rodrigues</text>
   <text y="145.583" x="417.184" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="148.103" x="420.109,422.359,424.609,429.613,431.863,438.361,442.357,444.859,449.359,453.859,458.359,462.859" svgx:width="0.25,0.25,0.56,0.25,0.72,0.44,0.28,0.5,0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Delongui</text>
   <text y="145.583" x="465.36" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="148.103" x="468.285,470.535,472.785,479.283,484.287,486.537,493.035,495.537,498.534,501.036,505.032,508.029" svgx:width="0.25,0.25,0.72,0.56,0.25,0.72,0.28,0.33,0.28,0.44,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, DF Alfieri</text>
   <text y="145.583" x="510.531" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="148.103" x="513.456,515.706" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="159.101" x="297.258,302.757,310.758,317.256,319.506,325.509,329.505,332.007,336.003,340.503" svgx:width="0.61,0.89,0.72,0.25,0.67,0.44,0.28,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">EMV Reiche</text>
   <text y="156.583" x="344.5" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="159.103" x="347.425,349.675,351.925,358.423,364.426,366.676,373.174,377.17,379.672,386.674,390.67,395.17,398.167,406.168,410.164,414.16,416.662,420.658" svgx:width="0.25,0.25,0.72,0.67,0.25,0.72,0.44,0.28,0.78,0.44,0.5,0.33,0.89,0.44,0.44,0.28,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, DR Kaimen-Maciel</text>
   <text y="156.583" x="423.159" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="167.581" x="297.261" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="170.103" x="300.185,306.683,311.183,313.685,317.681,321.677,325.178,328.679,331.181,335.681,340.181,344.681,348.677,350.927,356.426,359.927,362.429,366.929,371.429,375.929,380.429,382.931,385.181,389.681,393.677,395.927,400.931,405.431,409.931,414.431,417.932,420.434,424.934,429.434,431.684,433.934,438.938,443.438,447.938,452.438,455.939,458.441,462.941,467.441,469.691,471.941,477.44,480.941,485.441,488.942,491.444" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.5,0.5,0.5,0.44,0.25,0.61,0.39,0.28,0.5,0.5,0.5,0.5,0.28,0.25,0.5,0.44,0.25,0.56,0.5,0.5,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.56,0.5,0.5,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.61,0.39,0.5,0.39,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Universidade Estadual de Londrina, Londrina, Brazil</text>
   <text y="197.103" x="297.26,303.263,307.763,311.759,316.763,321.263,325.097,329.597,334.601,339.605,344.609,347.606" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="197.103" x="351.161,357.659,361.655,366.155,369.152,373.652,380.654,385.154,389.15,391.652,394.154,396.656,399.158,402.659,404.909,406.214,410.714,415.214,417.716,420.218,424.214,428.21,430.46,431.765,434.762,441.26,449.261,455.759,458.756,461.006,462.311,464.813,468.314,470.564,471.869,475.865,480.365,482.615,483.92,486.422,490.922,493.919,496.421,500.417,507.419,514.421,518.417,520.919,525.419,528.416,532.916" svgx:width="0.72,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.44,0.25,0.55,0.33,0.72,0.89,0.72,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Neuromyelitis optica (NMO) is an inflammatory </text>
   <text y="208.101" x="297.26,301.76,304.262,307.763,311.759,315.755,319.256,323.252,326.168,330.668,333.665,336.581,339.083,343.583,347.579,350.495,354.491,358.487,362.987,365.489,368.486,372.482,374.984,377.9,382.4,386.396,389.393,393.893,398.393,402.893,406.394,409.31,412.811,417.311,420.812,423.314,427.31,434.312,437.228,439.73,444.23,448.226,450.728,453.644,458.144,461.141,465.137,469.637,474.137,481.139,483.641,488.141,492.137,496.637,499.139,501.641,506.141,509.057,513.053,515.888,518.885,522.881,526.877,529.379,532.88" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.5,0.44,0.33,0.5,0.5,0.5,0.39,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.28,0.5,0.44,0.28,0.25,0.5,0.33,0.44,0.5,0.5,0.78,0.28,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disease of the central nervous system that predominantly affects </text>
   <text y="219.099" x="297.26,299.762,304.262,308.258,310.346,314.846,319.346,321.848,324.35,328.346,330.434,334.934,338.93,341.927,346.427,350.423,353.924,356.012,360.008,364.508,369.008,371.096,373.598,378.098,382.094,384.182,387.683,392.183,394.685,399.185,403.181,405.683,407.771,411.767,416.267,419.264,423.764,426.014,428.102,434.6,442.601,449.099,451.187,453.689,457.19,459.278,463.274,466.775,470.276,474.776,478.772,481.274,485.27,487.772,491.768,496.268,498.356,504.854,507.356,509.858,514.358,516.446,520.442,524.942,527.444,529.946" svgx:width="0.28,0.5,0.44,0.25,0.5,0.5,0.28,0.28,0.44,0.25,0.5,0.44,0.33,0.5,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.28,0.5,0.44,0.28,0.25,0.44,0.5,0.33,0.5,0.25,0.25,0.72,0.89,0.72,0.25,0.28,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the optic nerves and the spinal cord. NMO is associated with anti-</text>
   <text y="230.097" x="297.26,301.76,306.26,310.76,313.262,317.258,320.759,323.009,324.062,326.564,331.064,335.06,337.562,339.812,340.865,343.367,347.363,350.198,354.698,358.694,361.196,363.446,364.499,368.495,372.995,377.495,381.491,385.991,390.491,393.488,395.99,400.49,403.487,407.987,410.237,412.487,413.54,418.04,420.542,425.042,429.038,432.035,434.285,435.338,439.334,443.834,446.336,450.836,453.338,460.34,467.342,471.842,476.342,480.338,482.588,483.641,488.141,490.643,494.144,498.644,501.641,506.141,510.137,513.134,516.635,518.885,519.938,523.934,528.434,532.934" svgx:width="0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.44,0.5,0.5,0.33,0.28,0.5,0.33,0.5,0.25,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">bodies that target aquaporin-4, other autoimmune disorders and </text>
   <text y="241.095" x="297.26,304.262,308.762,311.264,313.766,316.268,320.768,323.27,327.266,329.516,331.469,335.969,338.471,342.971,346.967,349.964,352.214,354.167,358.163,362.663,365.165,369.665,373.661,378.161,380.663,383.165,387.665,392.165,396.665,399.167,403.163,406.664,408.914,411.164,412.622,418.625,420.875,422.828,426.329,428.831,433.331,437.831,440.333,444.329,448.829,451.079,453.032,455.534,460.034,464.03,468.53,471.032,473.534,476.531,479.033,483.029,487.529,489.779,491.732,496.232,500.732,502.982,504.935,508.931,513.431,515.933,520.433,522.935,529.937" svgx:width="0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.72,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">multiple other autoantibodies. A studied identified 22 autoim-</text>
   <text y="252.093" x="297.26,304.262,308.762,313.262,317.258,319.508,323.504,328.004,332.504,337.004,339.506,342.008,344.51,349.01,353.51,357.011,359.261,363.257,366.758,370.259,374.759,378.755,381.257,385.253,387.755,391.751,396.251,398.501,404.999,407.501,410.003,414.503,416.753,423.251,431.252,437.75" svgx:width="0.78,0.5,0.5,0.44,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mune conditions associated with NMO.</text>
   <text y="263.091" x="297.26,304.262,309.266,312.263,316.259,320.255,323.252,325.754,330.254,334.25,337.751,340.748" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="263.091" x="342.881,348.38,352.88,356.876,359.009,363.005,365.507,372.509,374.642,379.142,382.139,384.272,386.774,391.274,393.776,397.277,399.41,402.911,405.413,409.913,414.413,418.913,421.046,427.544,431.54,435.041,437.174,439.676,444.176,446.309,448.811,453.311,457.811,461.807,465.308,467.81,470.312,474.812,478.808,481.31,485.306,487.439,491.435,495.935,498.437,502.937,506.933,511.433,513.935,516.437,520.937,525.437,529.937" svgx:width="0.61,0.5,0.44,0.25,0.44,0.28,0.78,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The aim of this study was to investigate autoantibod-</text>
   <text y="274.089" x="297.26,299.762,303.758,307.259,309.509,312.011,316.511,318.761,323.261,327.257,329.759,332.261,336.257,340.757,343.259,346.76,349.01,355.508,358.01,360.512,365.012,367.262,373.76,381.761,388.259,390.509,393.506,396.503,401.003,408.005,410.255,415.259,419.759,424.259,426.761,431.261,435.257,438.254,442.754,445.004,451.007,454.004,458.0,461.996,464.498,467.0" svgx:width="0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.25,0.33,0.33,0.5,0.78,0.25,0.56,0.5,0.5,0.28,0.5,0.44,0.33,0.5,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ies in patients with NMO from Southern Brazil.</text>
   <text y="285.087" x="297.26,305.981,310.202,313.424,318.653,323.378,328.607,332.333,335.555" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="285.087" x="339.389,344.618,348.839,351.566,354.293,358.514,363.239,365.966,369.692,371.942,373.526,380.249,382.976,385.703,390.428,392.678,394.262,400.985,409.211,415.934,418.184,419.768,426.491,430.712,433.934,438.155,440.405,441.989,446.714,449.441,453.662,458.387,463.112,467.837,471.563,475.784,480.509,482.759,484.343,488.564,492.785,497.006,501.731,504.953,509.678,512.405,517.13,521.855,524.105,525.689,528.416,532.916" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.55,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients with NMO were diagnosed according to </text>
   <text y="296.085" x="297.26,299.987,304.712,308.933,311.12,315.845,320.57,325.295,330.02,332.207,335.429,339.65,344.375,347.102,350.828,355.049,359.774,361.961,366.686,369.413,373.634,378.359,383.084,387.809,391.535,394.262,396.989,401.21,403.397,407.618,410.84,413.567,416.294,420.515,423.737,426.464,430.685,433.16,435.347,442.07,446.291,453.518,458.243,462.968,466.19,470.411,475.136,479.861,482.588,486.809,488.996,493.217,497.942,502.667,504.854,509.075,511.802,514.529,519.254,521.981,526.202,530.423,532.925" svgx:width="0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.5,0.25,0.33,0.44,0.5,0.28,0.39,0.44,0.5,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.25,0.25,0.72,0.44,0.78,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the 2006 revised diagnostic criteria. Demographic and clinical </text>
   <text y="307.083" x="297.26,301.985,306.206,308.933,313.154,315.593,322.316,326.537,329.759,333.98,336.419,341.144,345.869,348.596,352.817,355.544,360.269,364.49,369.215,371.654,374.876,378.098,382.823,390.05,392.489,397.214,401.939,404.378,409.103,413.324,416.051,418.778,422.999,427.724,430.451,434.177,436.616,443.339,446.066,448.793,453.518,455.957,462.68,470.906,477.629,480.068,484.793,488.519,491.246,495.971,500.696,503.135,507.356,509.795,513.521,516.248,520.469,525.194,529.919" svgx:width="0.5,0.44,0.28,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.44,0.25,0.39,0.28,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">data were obtained from 22 patients with NMO using a stand-</text>
   <text y="318.081" x="297.26,301.481,304.703,309.428,311.894,316.619,321.344,325.565,329.291,332.018,334.745,339.47,344.195,348.92,353.141,355.868,359.09,363.311,365.777,369.998,374.723,379.448,381.914,385.136,388.358,393.083,400.31,402.776,410.003,414.224,418.949,421.676,425.897,430.118,432.845,435.311,438.533,442.754,446.975,451.7,454.922,459.647,463.373,465.848,467.819,474.542,477.269,479.996,482.462,487.187,491.408,494.135,496.862,501.083,505.808,508.535,512.261,514.727,521.45,525.671,528.893,532.889" svgx:width="0.44,0.33,0.5,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.78,0.44,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.44,0.5,0.33,0.5,0.39,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ard questionnaire and from medical records. All patients were </text>
   <text y="329.079" x="297.26,301.985,306.71,311.435,315.656,318.878,321.128,322.109,326.834,330.56,334.781,337.031,338.012,342.737,345.959,348.209,349.19,353.915,357.137,361.358,366.083,370.808,373.535,377.261,381.986,386.711,390.932,393.182,394.163,396.89,401.615,403.865,404.846,409.067,413.792,421.019,425.744,428.471,433.196,437.417,440.144,442.871,447.596,452.321,454.571,455.552,462.275,465.002,467.729,472.454,474.704,475.685,480.41,483.137,487.862,492.083,495.305,497.555,498.536,501.263,508.49,515.717,520.442,525.167,529.892" svgx:width="0.5,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.44,0.5,0.5,0.28,0.39,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">under use of prednisone in combination with other immuno-</text>
   <text y="340.077" x="297.26,300.986,305.711,310.436,315.161,318.383,322.604,326.33,330.056,332.783,337.508,341.729,343.979,346.526,351.251,354.473,359.198,363.923,366.173,368.72,371.942,376.163,380.384,384.605,387.332,392.057,394.784,399.509,404.234,407.456,410.183,414.908,419.129,421.379,423.926,428.651,431.873,434.123,436.67,443.897,448.622,452.843,457.568,462.293,467.018,471.239,475.964,480.689,483.416,487.637,490.364,495.089,497.339,499.886,507.113,511.838,515.06,519.281,522.008,524.735,527.462,530.684,532.934" svgx:width="0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.5,0.28,0.5,0.5,0.33,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.5,0.44,0.5,0.5,0.5,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.78,0.5,0.33,0.44,0.28,0.28,0.28,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">suppressive drug (azathioprine or mycophenolato mofetil). </text>
   <text y="351.075" x="297.26,302.489,306.71,309.437,312.164,316.385,321.11,323.837,327.563,329.813,331.91,338.633,342.854,346.076,350.297,352.547,354.644,359.369,362.096,366.821,369.548,374.273,378.494,383.219,385.469,387.566,390.293,395.018,397.268,399.365,404.09,407.312,412.037,416.762,421.487,423.737,425.834,430.559,433.034,435.284,437.381,441.602,446.327,451.052,454.778,457.505,461.231,463.958,468.179,472.904,475.154,477.251,481.976,485.198,487.448,489.545,494.27,498.995,501.245,503.342,508.067,512.288,515.015,517.742,521.963,526.688,529.415,532.916" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.28,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.25,0.55,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients were divided in group 1, consisted of 13 patients </text>
   <text y="362.073" x="297.26,301.985,306.71,311.435,315.656,318.878,321.173,325.898,329.624,333.845,336.14,340.865,344.087,346.382,351.107,355.832,358.127,365.354,370.079,372.806,377.531,381.752,386.477,388.772,393.497,396.719,399.014,403.739,406.961,411.182,415.907,420.632,423.359,427.085,431.81,436.535,440.756,443.483,445.778,449.999,454.724,459.449,461.744,468.467,471.689,476.414,481.139,485.864,488.159,492.884,495.359,497.654,501.875,506.6,511.325,515.051,517.778,521.504,524.231,528.452,532.952" svgx:width="0.5,0.5,0.5,0.44,0.33,0.25,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.78,0.5,0.28,0.5,0.44,0.5,0.25,0.5,0.33,0.25,0.5,0.33,0.44,0.5,0.5,0.28,0.39,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.72,0.33,0.5,0.5,0.5,0.25,0.5,0.25,0.25,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">under use of 10 mg/day of prednisone; and Group 2, consisted </text>
   <text y="373.071" x="297.26,301.985,305.207,307.061,311.786,313.64,318.365,322.586,325.313,328.04,332.261,336.986,339.713,343.439,345.293,350.018,354.743,359.468,363.689,366.911,368.765,373.49,377.216,381.437,383.291,388.016,391.238,393.092,398.393,403.118,407.843,415.07,419.795,422.522,427.247,431.468,436.193,438.047,442.772,445.994,447.848,452.573,455.795,460.016,464.741,469.466,472.193,475.919,480.644,485.369,489.59,492.065,493.919,499.148,503.369,506.591,509.318,514.043,518.768,522.989,526.211,530.432,532.934" svgx:width="0.5,0.33,0.25,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.56,0.5,0.5,0.78,0.5,0.28,0.5,0.44,0.5,0.25,0.5,0.33,0.25,0.5,0.33,0.44,0.5,0.5,0.28,0.39,0.5,0.5,0.44,0.25,0.25,0.56,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of 9 patients under use of &gt;10mg/day of prednisone. Peripheral </text>
   <text y="384.069" x="297.26,301.985,304.712,309.437,314.162,318.887,321.047,324.773,328.994,336.221,340.946,343.673,347.894,351.62,353.78,360.503,364.724,367.946,372.167,374.327,378.548,383.273,386.0,388.727,392.948,397.169,399.896,404.117,408.842,411.002,413.729,418.454,420.614,423.341,427.562,431.288,434.015,436.175,440.396,445.121,447.848,450.575,455.3,460.025,464.75,467.477,471.698,475.424,477.584,480.311,485.036,487.196,491.417,496.142,500.867,505.088,509.813,514.538,517.76,520.487,525.212,528.434,532.934" svgx:width="0.5,0.28,0.5,0.5,0.5,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.44,0.39,0.28,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.44,0.5,0.5,0.33,0.28,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">blood samples were collected to test antibodies to aquaporin-4 </text>
   <text y="395.067" x="297.26,300.482,304.703,309.428,312.155,314.882,318.104,324.827,331.55,336.779,341.504,344.726,347.201,349.451,352.997,355.724,360.449,365.174,368.396,373.121,375.848,380.573,383.795,387.521,390.248,392.975,400.202,404.927,407.654,411.875,414.602,417.329,422.054,426.779,429.029,432.575,437.3,442.025,445.247,452.474,457.199,461.924,466.145,468.395,471.941,475.163,480.887,486.116,492.839,496.061,498.311,501.857,505.079,509.3,513.521,517.742,522.467,525.194,529.919,532.916" svgx:width="0.33,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.33,0.25,0.25,0.55,0.28,0.5,0.5,0.33,0.5,0.28,0.5,0.33,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.33,0.78,0.5,0.5,0.44,0.25,0.55,0.33,0.61,0.56,0.72,0.33,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(anti-AQP4), thyroid-stimulating hormone (TSH) receptor </text>
   <text y="406.065" x="297.26,301.481,306.206,308.933,311.66,316.385,321.11,325.835,328.562,332.783,336.509,338.813,342.035,347.759,353.987,360.71,365.435,368.657,371.132,373.436,377.657,382.382,385.109,387.836,392.561,397.286,401.507,404.234,408.455,412.676,415.898,418.202,422.423,427.148,429.875,432.602,437.327,442.052,446.777,449.504,453.725,457.451,459.755,462.977,469.7,476.423,483.146,486.368,488.843,491.147,495.368,500.093,502.82,505.547,508.274,512.999,517.724,520.946,525.671,528.398,532.898" svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.61,0.67,0.72,0.5,0.33,0.25,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.72,0.72,0.72,0.33,0.25,0.25,0.44,0.5,0.28,0.28,0.28,0.5,0.5,0.33,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antibodies (TRAb), antinuclear antibodies (ANA), antithyroid </text>
   <text y="417.063" x="297.26,301.985,306.206,309.428,314.153,318.878,321.605,326.33,330.551,334.277,338.498,341.324,345.545,350.27,352.997,355.724,360.449,365.174,369.899,372.626,376.847,380.573,383.399,386.621,390.842,395.567,398.294,401.021,406.745,411.974,418.697,421.919,424.394,427.22,431.441,436.166,438.893,441.62,444.347,447.074,450.296,454.517,459.242,463.967,466.694,471.419,476.144,480.869,483.596,486.323,491.048,493.874,498.095,502.82,505.547,508.274,512.999,517.724,522.449,525.176,529.397,532.898" svgx:width="0.5,0.44,0.33,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.44,0.5,0.28,0.28,0.61,0.56,0.72,0.33,0.25,0.25,0.44,0.5,0.28,0.28,0.28,0.28,0.33,0.44,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">peroxidase antibodies (antiTPO), antitireoglobulin antibodies </text>
   <text y="428.061" x="297.26,301.481,306.206,310.931,313.181,314.936,319.157,323.882,326.609,329.336,334.061,338.786,343.511,346.238,350.459,354.185,356.435,358.19,360.917,365.642,367.892,369.647,374.372,379.097,383.822,388.547,391.274,395.495,397.745,399.5,403.226,405.953,409.175,413.396,418.121,422.846,427.067,431.792,434.042,435.797,442.52,449.243,455.471,457.721,459.476,462.698,466.919,471.644,474.371,477.098,480.32,485.045,488.771,495.494,502.217,508.94,512.162,514.637,516.887,518.48,524.204,528.929,532.925" svgx:width="0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.25,0.55,0.39,0.28,0.33,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.72,0.72,0.72,0.25,0.55,0.33,0.44,0.5,0.28,0.28,0.33,0.5,0.39,0.72,0.72,0.72,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and antibodies to double stranded DNA (anti-dsDNA). The </text>
   <text y="439.059" x="297.26,301.985,304.712,308.438,312.659,317.384,320.111,322.838,325.565,328.292,333.017,335.555,342.278,346.499,350.225,352.763,356.984,361.709,365.93,368.657,373.382,377.603,380.33,384.551,389.276,391.814,396.539,400.265,402.992,407.717,412.442,414.98,417.707,422.432,426.653,429.191,434.915,439.64,444.365,448.586,453.311,458.036,462.257,466.982,469.52,476.243,478.97,482.696,486.917,491.642,494.369,497.096,499.823,502.55,507.275,509.813,515.042,517.769,521.99,524.717,529.442,532.943" svgx:width="0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.61,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.72,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.56,0.28,0.44,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disability was evaluated using the Expanded Disability Status </text>
   <text y="450.057" x="297.26,302.489,306.71,310.931,313.658,317.879,320.354,323.576,329.3,336.023,341.252,346.481,349.703" svgx:width="0.56,0.44,0.44,0.28,0.44,0.25,0.33,0.61,0.72,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Scale (EDSS).</text>
   <text y="461.055" x="297.26,303.758,307.754,311.255,316.259,318.761,321.758,325.259,328.256" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="461.055" x="330.821,337.319,341.819,344.384,348.884,351.386,354.221,357.218,361.214,364.211,368.207,372.707,376.703,380.699,383.264,389.762,393.758,397.259,399.824,402.821,407.321,411.821,416.321,420.821,423.386,425.888,430.388,432.953,436.949,441.449,445.445,447.695,450.26,454.76,458.756,463.256,467.756,471.752,474.389,476.639,479.204,483.2,485.702,490.202,494.702,497.204,501.2,503.702,506.204,510.119,512.369,514.934,519.434,523.934,528.434,532.934" svgx:width="0.72,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.72,0.44,0.39,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.25,0.25,0.5,0.44,0.5,0.5,0.44,0.33,0.25,0.25,0.44,0.28,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">No difference was found in age, gender, ethnicity, body </text>
   <text y="472.053" x="297.26,304.262,308.258,311.759,315.26,317.51,320.534,323.036,327.536,332.036,336.032,340.532,342.782,345.032,348.056,352.052,356.552,361.052,363.302,366.326,370.322,374.822,377.819,380.321,382.823,386.819,391.319,394.82,397.322,401.318,404.315,408.815,411.317,415.817,419.318,421.568,424.592,427.094,431.594,435.59,438.587,442.583,447.083,451.583,453.833,456.857,461.357,465.353,467.855,474.353,478.349,482.345,486.845,489.095,492.119,494.621,499.121,503.117,505.367,508.391,512.891,515.888,520.388,524.888,529.388,532.889" svgx:width="0.78,0.44,0.39,0.39,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.33,0.28,0.28,0.44,0.5,0.39,0.28,0.44,0.33,0.5,0.28,0.5,0.39,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mass index, and corticosteroids therapy between the groups </text>
   <text y="483.051" x="297.26,300.257,304.757,309.833,314.333,316.583,321.083,325.583,328.58,330.83,333.08,334.142,339.641,344.141,348.137,350.387,351.611,358.613,362.609,367.109,369.611,373.607,378.107,380.357,381.581,385.577,390.077,394.073,396.323,397.547,402.047,405.044,407.294,408.518,413.018,415.52,419.021,423.017,427.013,430.514,434.51,436.76,437.984,442.484,446.984,450.485,454.481,456.983,459.233,460.457,464.453,468.953,473.453,475.703,476.927,483.929,487.925,492.425,494.927,498.923,503.423,505.673,506.897,511.397,513.899,517.4,521.396,525.392,528.893,532.889" svgx:width="0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(p&gt;0.05). The median age of disease onset and median disease </text>
   <text y="494.049" x="297.26,301.76,306.26,309.257,313.253,315.755,318.257,322.757,327.257,329.687,336.185,340.181,343.682,346.112,350.612,353.114,357.614,362.114,366.11,369.107,371.537,376.037,380.537,382.967,387.467,390.464,394.964,399.464,403.964,406.394,410.894,413.324,415.826,420.326,424.322,428.822,431.252,435.752,438.749,443.249,447.749,452.249,454.679,459.179,461.609,464.606,469.106,473.606,475.856,480.356,482.786,487.286,490.787,493.217,497.717,502.217,504.467,508.967,511.397,515.897,519.893,523.889,526.886,530.387,532.889" svgx:width="0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.5,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.5,0.25,0.33,0.5,0.5,0.25,0.5,0.25,0.5,0.39,0.25,0.5,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">duration was higher on group 1 than group 2 (48.5 vs 37.0 years; </text>
   <text y="505.047" x="297.26,301.76,306.836,311.336,313.586,318.086,322.586,327.086,331.586,334.088,336.374,340.874,343.124,347.624,349.91,354.41,357.911,360.197,364.697,366.983,371.483,375.479,379.475,382.472,385.973,388.223,390.509,395.009,400.085,404.585,406.835,411.335,415.835,420.335,424.835,427.832,430.082,431.873,438.371,440.873,443.375,447.875,452.375,456.875,461.375,465.875,468.161,472.661,476.657,479.159,481.661,485.657,490.157,492.659,496.16,498.446,502.946,505.943,509.939,513.44,517.436,521.936,524.438,528.434,532.934" svgx:width="0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.25,0.5,0.25,0.5,0.25,0.5,0.39,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.72,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">p=0.0482; 7.0 vs 2 years, p=0.0240). Although patients presented </text>
   <text y="516.045" x="297.26,301.76,304.262,308.762,312.758,315.755,319.256,321.992,325.988,330.488,332.99,337.49,339.992,346.994,353.996,358.496,362.996,366.992,369.728,374.228,376.73,380.231,384.227,388.223,391.724,395.72,399.221,401.957,404.954,408.455,412.955,416.456,418.958,422.954,429.956,432.458,436.454,439.19,441.692,446.192,450.692,455.192,458.693,461.429,465.425,468.422,472.922,475.424,479.924,483.92,490.922,494.918,497.42,501.92,505.421,509.921,513.422,515.672,518.408,521.909,526.409,529.91" svgx:width="0.5,0.28,0.5,0.44,0.33,0.39,0.25,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.33,0.39,0.5,0.39,0.28,0.44,0.78,0.28,0.44,0.25,0.28,0.5,0.5,0.5,0.39,0.25,0.44,0.33,0.5,0.28,0.5,0.44,0.78,0.44,0.28,0.5,0.39,0.5,0.39,0.25,0.25,0.39,0.5,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">others autoimmune diseases (systemic lupus erythematosus, sys-</text>
   <text y="527.043" x="297.26,299.762,303.758,310.76,313.262,317.258,319.508,321.839,325.34,329.336,331.838,335.834,338.831,343.331,346.832,349.334,352.835,355.085,357.335,359.666,362.168,366.668,371.168,375.164,379.664,382.166,384.668,388.664,390.914,393.245,396.242,400.742,404.738,409.238,416.24,420.236,422.738,427.238,429.74,434.24,436.49,438.821,442.817,445.814,448.316,452.816,455.813,458.315,460.817,463.319,466.82,469.07,471.32,473.651,478.151,482.651,487.151,491.651,494.153,498.653,503.153,506.15,510.65,513.152,517.652,520.154,523.655,530.657,532.907" svgx:width="0.28,0.44,0.78,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.55,0.33,0.5,0.44,0.5,0.78,0.44,0.28,0.5,0.28,0.5,0.25,0.55,0.44,0.33,0.28,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.28,0.5,0.28,0.39,0.78,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">temic sclerosis, juvenile rheumatoid arthritis, hypothyroidism, </text>
   <text y="538.041" x="297.26,301.76,306.26,310.76,314.756,317.753,320.255,324.755,329.255,332.252,336.752,339.254,343.754,346.256,349.757,356.759,359.009,361.439,365.435,369.935,374.435,376.685,379.115,385.118,389.114,393.614,398.114,402.11,406.61,411.11,413.612,417.113,419.363,421.793,426.293,430.793,434.789,439.289,443.789,450.791,454.787,459.287,463.787,468.287,471.284,473.534,475.784,478.214,482.714,487.214,489.464,491.894,495.395,497.897,501.893,504.395,506.897,510.398,512.9,515.402,519.398,523.394,525.896,528.398,532.898" svgx:width="0.5,0.5,0.5,0.44,0.33,0.28,0.5,0.5,0.33,0.5,0.28,0.5,0.28,0.39,0.78,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.44,0.5,0.5,0.44,0.5,0.5,0.33,0.39,0.25,0.55,0.5,0.5,0.44,0.5,0.5,0.78,0.44,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">hyperthyroidism and Raynaud’s phenomenon), no statistically </text>
   <text y="549.039" x="297.26,300.761,303.263,307.763,312.263,314.765,317.762,320.264,324.26,328.256,332.756,335.258,337.508,338.867,343.367,345.869,348.704,351.701,355.697,358.694,362.69,367.19,371.186,375.182,378.683,380.933,382.292,388.79,392.786,395.783,399.779,402.029,403.388,406.385,410.885,415.385,419.885,424.385,426.635,427.994,430.496,434.996,437.246,438.605,442.601,447.101,449.603,452.105,455.102,461.6,468.098,473.102,477.602,479.852,482.102,483.299,488.798,494.801,501.299,505.799,508.049,510.299,511.163,517.661,524.159,530.657,532.907" svgx:width="0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.25,0.55,0.61,0.67,0.72,0.5,0.25,0.25,0.55,0.72,0.72,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">significant differences were found in anti-AQP4, TRAb, ANA, </text>
   <text y="560.037" x="297.26,301.256,305.756,308.258,310.76,316.259,321.263,327.761,330.011,331.523,335.519,340.019,344.519,346.769,348.281,352.277,356.777,359.279,361.781,364.283,366.785,369.782,373.778,378.278,382.778,385.28,389.78,394.28,398.78,401.282,403.784,408.284,410.534,412.046,416.042,420.542,423.044,425.546,430.046,434.546,439.046,441.548,445.544,449.045,451.295,452.807,455.804,460.304,465.38,469.88,472.13,476.63,481.13,484.127,486.377,488.627,489.644,496.142,498.644,501.146,503.396,504.908,509.408,513.404,515.906,518.408,522.404,526.904,529.406,532.907" svgx:width="0.44,0.5,0.28,0.28,0.61,0.56,0.72,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.28,0.28,0.33,0.44,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antiTPO and antitireoglobulin antibodies (p&gt;0.05). All patients </text>
   <text y="571.035" x="297.26,303.758,307.754,310.751,314.747,316.628,321.128,325.124,329.624,333.62,336.122,338.624,343.124,347.12,349.001,351.998,356.498,359.495,361.376,365.372,369.872,372.374,374.876,377.873,382.373,385.874,392.372,398.87,404.873,406.754,409.256,411.758,414.26,418.256,421.253,424.754,427.004,428.885,433.889,437.885,440.387,442.889,446.885,451.385,453.887,457.388,459.269,462.266,465.263,469.763,476.765,478.646,481.148,485.648,488.15,491.651,493.532,497.528,502.028,506.528,511.028,514.025,516.527,518.408,522.908,525.905,529.901" svgx:width="0.72,0.44,0.33,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.33,0.5,0.39,0.72,0.72,0.72,0.25,0.28,0.28,0.28,0.44,0.33,0.39,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were negative for anti-dsDNA titers. Patients from this cohort pre-</text>
   <text y="582.033" x="297.26,300.761,304.757,309.257,311.759,315.755,320.255,322.271,326.771,331.271,333.773,338.273,340.289,344.789,349.289,356.786,358.802,363.302,366.299,368.315,372.311,376.811,379.313,381.815,384.812,391.31,397.808,402.812,407.312,409.328,413.828,418.328,421.829,424.331,426.833,429.335,433.835,436.337,438.839,442.754,445.004,447.02,453.518,458.018,460.034,464.534,467.036,469.871,472.868,476.864,479.861,483.857,488.357,492.353,496.349,499.85,501.866,504.368,508.868,510.884,516.383,522.881,527.885,532.889" svgx:width="0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25,0.72,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.39,0.25,0.28,0.5,0.25,0.61,0.72,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sented only 50% of anti-AQP4 positivity. No differences in EDSS </text>
   <text y="593.031" x="297.26,303.758,307.754,310.751,314.747,316.997,319.994,324.494,328.994,333.494,337.994,340.244,343.241,347.741,352.817,357.317,359.567,364.067,368.567,371.564" svgx:width="0.72,0.44,0.33,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were found (p&gt;0.05).</text>
   <text y="604.029" x="297.26,303.758,308.258,313.262,317.258,319.76,324.764,328.265,330.767,335.267,340.271,343.772,346.769" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="604.029" x="349.082,354.086,358.082,360.584,363.086,367.082,371.582,374.084,377.585,379.898,386.396,388.898,391.4,395.9,398.213,404.711,412.712,419.21,421.523,426.023,429.02,433.016,436.517,440.513,445.013,447.515,451.511,456.011,458.324,462.32,464.633,468.629,473.129,477.629,480.131,483.128,487.628,492.128,496.124,499.121,502.622,505.124,509.12,511.622,513.935,517.931,520.433,522.935,527.435,529.937" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.44,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.5,0.44,0.33,0.39,0.28,0.44,0.28,0.25,0.44,0.28,0.28,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients with NMO presented a controversial clini-</text>
   <text y="615.027" x="297.26,301.256,305.252,307.754,310.355,314.351,318.851,323.351,325.961,328.463,332.459,336.959,341.459,344.456,348.452,350.954,355.454,358.451,360.953,364.949,367.451,370.052,374.048,378.548,383.048,386.045,389.546,393.542,395.792,398.393,406.394,410.894,413.891,417.887,420.488,423.989,426.491,430.991,435.491,437.993,441.989,445.49,448.1,451.601,456.101,460.601,465.101,467.603,472.103,474.704,479.204,483.2,485.81,490.31,494.306,497.303,500.3,504.8,507.797,514.799,518.795,523.295,525.896,528.398,532.898" svgx:width="0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.5,0.33,0.28,0.44,0.28,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.89,0.5,0.33,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.39,0.5,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cal and laboratorial course. More studies should be performed to </text>
   <text y="626.025" x="297.26,301.256,303.758,307.754,310.751,313.253,316.25,320.75,323.0,325.502,330.002,333.998,336.248,340.244,342.746,345.248,349.748,352.25,356.246,360.242,362.744,364.994,368.99,373.49,377.99,380.24,382.742,386.738,391.238,395.738,398.735,402.731,405.233,409.733,412.73,415.232,419.228,421.73,423.98,427.976,432.476,436.976,439.973,443.474,447.47,449.72,454.22,457.217,459.467,461.969,466.469,470.465,472.715,477.215,479.717,483.218,487.214,491.21,494.711,498.707" svgx:width="0.44,0.28,0.44,0.33,0.28,0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.5,0.33,0.28,0.44,0.28,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clarify the clinical and laboratorial course of the disease.</text>
   <text y="653.025" x="297.26,302.759,307.259,311.759" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P649</text>
   <text y="664.023" x="297.26,303.758,307.754,312.758,316.754,321.254,328.751,333.251,337.247,339.749,342.251,345.248,347.75,351.251,353.501,358.001,363.005,366.002,368.504,372.5,377.0,379.997,382.247,386.747,391.751,396.755,401.759,406.259,408.761,411.011,415.007,419.003,421.505,426.005,431.009,434.51,438.506,440.756,444.752,449.252,452.249,456.245,459.746,461.996,466.496,469.493,472.49,474.74,479.24,484.244,489.248,491.498,495.998,501.002" svgx:width="0.72,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.5,0.56,0.33,0.28,0.44,0.5,0.33,0.25,0.5,0.56,0.56,0.56,0.5,0.28,0.25,0.44,0.44,0.28,0.5,0.56,0.39,0.44,0.25,0.44,0.5,0.33,0.44,0.39,0.25,0.5,0.33,0.33,0.25,0.5,0.56,0.56,0.25,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Neuromyelitis optica: annual relapse rates off and on </text>
   <text y="675.021" x="297.26,299.762,307.259,314.756,319.76,324.764,329.264,332.765,337.769,342.773,347.777,351.773,355.769,359.27,362.771,365.273,369.773,374.777,377.027,381.527,386.531,391.535,393.785,396.782,401.786,405.782,408.032,412.028,416.024,418.526,423.026,426.023,428.525,433.025,438.029,441.53,446.534,449.036,454.04,456.29,459.287,463.787,466.037,470.537,473.534,476.531,481.031,485.027,490.031,492.281,495.278,499.778,504.782,508.778" svgx:width="0.28,0.83,0.83,0.56,0.56,0.5,0.39,0.56,0.56,0.56,0.44,0.44,0.39,0.39,0.28,0.5,0.56,0.25,0.5,0.56,0.56,0.25,0.33,0.56,0.44,0.25,0.44,0.44,0.28,0.5,0.33,0.28,0.5,0.56,0.39,0.56,0.28,0.56,0.25,0.33,0.5,0.25,0.5,0.33,0.33,0.5,0.44,0.56,0.25,0.33,0.5,0.56,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">immunosuppression and the relationship to attack type </text>
   <text y="686.019" x="297.26,301.76,306.764,311.768,314.018,318.014,321.011,326.015,331.019,333.521,337.517,340.019,343.016" svgx:width="0.5,0.56,0.56,0.25,0.44,0.33,0.56,0.56,0.28,0.44,0.28,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">and ethnicity</text>
   <text y="697.017" x="297.26,303.758,306.008,311.507,315.503,319.499,323.999,326.501,330.497" svgx:width="0.72,0.25,0.61,0.44,0.44,0.5,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">G Tackley</text>
   <text y="694.583" x="334.996" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="697.103" x="337.921,340.171,342.421,347.425,349.675,356.173,359.17,365.173,368.17,370.672,374.668" svgx:width="0.25,0.25,0.56,0.25,0.72,0.33,0.67,0.33,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F O’Brien</text>
   <text y="694.583" x="379.168" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="697.103" x="382.093,384.343,386.593,394.594,397.591,399.841,405.34,409.336,411.838,414.34" svgx:width="0.25,0.25,0.89,0.33,0.25,0.61,0.44,0.28,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MI Leite</text>
   <text y="694.583" x="418.335" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="697.103" x="421.26,423.51,425.76,434.256,436.506,445.002,448.998,452.499,455.001,458.997,465.495,468.996,473.496" svgx:width="0.25,0.25,0.94,0.25,0.94,0.44,0.39,0.28,0.44,0.72,0.39,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, W Wasiewski</text>
   <text y="694.583" x="475.997" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="697.103" x="478.922,481.172,483.422,486.923,489.173,494.177,498.173,500.676,504.672,508.668" svgx:width="0.25,0.25,0.39,0.25,0.56,0.44,0.28,0.44,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Palace</text>
   <text y="694.583" x="512.663" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="705.581" x="297.26" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="708.103" x="300.185,306.683,310.679,313.181,317.681,321.182,325.682,327.932,334.43,338.93,341.432,345.428,349.424,352.925,356.426,358.928,361.43,365.426,367.676,374.174,378.674,382.175,386.675,389.177,391.679,396.179,398.681,402.182,404.432,410.435,416.933,421.433,423.683,428.687,432.188,436.688,440.189,442.691,444.941,447.191,453.194,457.694,460.196,462.698,465.2,469.196,471.698,476.198,478.448,484.946,488.942,493.442,497.942,501.443,503.945,510.443,514.439,518.939,521.441" svgx:width="0.72,0.44,0.28,0.5,0.39,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.39,0.25,0.67,0.72,0.5,0.25,0.56,0.39,0.5,0.39,0.28,0.25,0.25,0.67,0.5,0.28,0.28,0.28,0.44,0.28,0.5,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Oxford University Hospitals NHS Trust, Nuffield Department </text>
   <text y="719.101" x="297.26,301.76,304.262,306.512,312.515,315.017,317.519,322.019,324.521,328.517,333.017,335.519,337.769,343.772,347.768,352.268,355.769,360.269,362.771,367.271,371.771,375.767,378.017,380.267,386.765,390.761,393.263,397.763,401.264,405.764,408.014,410.264,416.762,421.262,423.764,426.266,430.262,434.762,437.012,443.015,445.517,450.017,454.517,459.017,463.517,470.015,472.265" svgx:width="0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.72,0.44,0.28,0.5,0.39,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">of Clinical Neurology, Oxford, United Kingdom, </text>
   <text y="716.583" x="474.513" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="719.103" x="477.438,482.937,485.439,489.435,493.431,495.933,500.433,504.933" svgx:width="0.61,0.28,0.44,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Alexion </text>
   <text y="730.101" x="297.258,302.757,307.257,311.757,315.258,321.756,326.256,330.252,334.248,338.748,341.25,343.752,347.748,352.248,354.75,358.251,360.501,362.751,368.754,373.254,377.25,380.751,385.251,387.753,391.254,395.25,397.5,399.75,405.753,410.757,413.007,415.257,421.755,426.255,428.757,431.259,435.255,439.755,442.005,446.505,449.007,453.507,456.009,460.005" svgx:width="0.61,0.5,0.5,0.39,0.72,0.5,0.44,0.44,0.5,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.67,0.5,0.44,0.39,0.5,0.28,0.39,0.44,0.25,0.25,0.67,0.56,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Pharmaceuticals, Cheshire, CT, United States</text>
  </g>
 </g>
</svg>
